Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission
Clinical trial NCT01503632 · COMPLETED
Trial details
- NCT number
- NCT01503632
- Sponsor
- Children's Oncology Group
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-21
- Primary completion
- 2019-06-30
- Enrollment
- 570
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.